Home Research-feed Channel Rankings GCT THU AI TR Open Data Must Reading

views: 0

Burch Ronald M

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers7 papers

Sort

By YearBy Citation

Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder

Omer Linkovski,Hanyang Shen,Jordana Zwerling, Maria Filippou-Frye,Booil Jo, Elisabeth Cordell,Thomas B. Cooper,Helen Blair Simpson,Ronald M. Burch,Joseph R. Moskal,Francis S. Lee,Carolyn I. Rodriguez

The Journal of Clinical Psychiatry, no. 1 (2018)

Cited by1Bibtex

853. Effect of a Novel NMDA Receptor Modulator, Rapastinel (formerly GLYX-13) in OCD: Proof-Of-Concept

Carolyn I. Rodriguez,Jordana Zwerling,Eyal Kalanthroff,Hanyang Shen,Maria Filippou,Booil Jo,H. Blair Simpson,Ronald M. Burch,Joseph R. Moskal

Biological Psychiatry, no. 10 (2017)

Bibtex

Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept

Carolyn I Rodriguez,Jordana Zwerling,Eyal Kalanthroff,Hanyang Shen,Maria Filippou,Booil Jo, Helen Blair Simpson,Ronald M Burch,Joseph R Moskal

The American journal of psychiatry, no. 12 (2016): 1239-1241

WOSBibtex

The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus

Jeffrey Burgdorf,X L Zhang,Craig Weiss, Amanda L Gross, S R Boikess,Roger A Kroes, Mahweesh Khan,Ronald Burch, C S Rex,John F Disterhoft,Patric K Stanton,Joseph R Moskal

Neuroscience, (2015)

Cited by36Bibtex

Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats

Jeffrey Burgdorf,Roger A Kroes,Xiaolei Zhang, Amanda L Gross,Mary Lou Schmidt,Craig Weiss,John F Disterhoft,Ronald Burch,Patric K Stanton,Joseph R Moskal

Behavioural Brain Research, (2015): 177-185

Cited by20Bibtex

(278) GLYX-13, an N-methyl-D-aspartate functional glycine site partial agonist, is efficacious in rat surgical models of neuropathic pain

Joseph R Moskal,Ronald Burch, N Ghoreishihaack,Jeffrey Burgdorf

The Journal of Pain, (2015)

Bibtex

Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent

Preskorn Sheldon,Macaluso Matthew,Mehra D O Vishaal,Zammit Gary,Moskal Joseph R,Burch Ronald M, Null Null

Journal of psychiatric practice, no. 2 (2015): 140-149

Cited by8WOSBibtex

View All

Base Info Papers Patents Projects